©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Meta-Anal. Aug 28, 2020; 8(4): 309-319
Published online Aug 28, 2020. doi: 10.13105/wjma.v8.i4.309
Published online Aug 28, 2020. doi: 10.13105/wjma.v8.i4.309
Importance of reporting quality: An assessment of the COVID-19 meta-analysis laboratory hematology literature
John L Frater, Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, United States
Author contributions: The entire manuscript was researched and written by Frater JL .
Conflict-of-interest statement: Authors declare no conflict of interests for this article.
PRISMA 2009 Checklist statement: This study was written according to the PRISMA 2009 Checklist.
Corresponding author: John L Frater, MD, Associate Professor, Department of Pathology and Immunology, Washington University School of Medicine, 660 South Euclid Avenue, Box 8118, St. Louis, MO 63110, United States. jfrater@wustl.edu
Received: June 8, 2020
Peer-review started: June 8, 2020
First decision: July 3, 2020
Revised: July 17, 2020
Accepted: August 27, 2020
Article in press: August 27, 2020
Published online: August 28, 2020
Processing time: 93 Days and 11.3 Hours
Peer-review started: June 8, 2020
First decision: July 3, 2020
Revised: July 17, 2020
Accepted: August 27, 2020
Article in press: August 27, 2020
Published online: August 28, 2020
Processing time: 93 Days and 11.3 Hours
Core Tip
Core Tip: The Institutes of Medicine, Preferred Reporting Items for Systemic Reviews and Meta-analyses, and Meta-analyses of Observational Studies in Epidemiology checklists were created to standardize the reporting quality of a meta-analysis. The purpose of this study was to use these checklists to assess the reporting quality of the coronavirus disease-2019 meta-analysis literature relevant to laboratory hematology.